
Prediction: 1 Biotech Stock That Could Surpass Pfizer by 2030
Investing vchal / Getty Images 24/7 Wall St. Insights: Pfizer (PFE) has been a behemoth in pharmaceuticals and drug development for decades, but lately has run into headwinds from vaccine sales, patent expiry, and more. That opens the door for …